Page last updated: 2024-08-21

pyrazines and Hepatitis B

pyrazines has been researched along with Hepatitis B in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's2 (20.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, S; Desmond, PV; Goldberg, R; Smith, E; Thompson, A1
Chawla, PS; Kochar, MS1
Bandi, P; Booth, CJ; Chisari, FV; Garcia, ML; Robek, MD1
Beysel, S; Yağci, M; Yeğın, ZA1
Cho, SH; Choi, JY; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, YS; Um, SH; Yu, E1
Goh, YT; Han, ST; Hwang, WY; Linn, YC; Mya, DH; Tan, DC1
Hashimoto, S; Nakaseko, C; Sakai, S; Sakuma, I; Shimura, T; Takagi, T; Takeda, Y; Tanaka, H1
Groopman, JD; Kensler, TW1
Chen, B; Davidson, NE; Egner, PA; Enger, C; Fang, X; Gordon, GB; Gorman, MB; Groopman, JD; Helzlsouer, KJ; Jacobson, LP; Kensler, TW; Kuang, SY; Li, YF; Muñoz, A; Prochaska, HJ; Qian, GS; Wang, JB; Wu, Y; Yu, LY; Zarba, A; Zhang, BC; Zhang, QN; Zhu, YR1
Alaoui-Jamali, MA; Batist, G; Fotouhi-Ardakani, N; Jaitovitch-Groisman, I; Schecter, RL; Woo, A1

Reviews

2 review(s) available for pyrazines and Hepatitis B

ArticleYear
What's new in clinical pharmacology and therapeutics.
    WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2

    Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines

2008
Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
    Journal of cellular biochemistry. Supplement, 1996, Volume: 25

    Topics: Aflatoxin B1; Aflatoxins; Aged; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinogens; Clinical Trials as Topic; Cohort Studies; DNA Adducts; Guanine; Hepatitis B; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Proteins; Pyrazines; Risk Factors; Thiones; Thiophenes

1996

Trials

2 trial(s) available for pyrazines and Hepatitis B

ArticleYear
Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:5

    Topics: Adult; Anticarcinogenic Agents; Biomarkers; Biopsy; Collagen; Double-Blind Method; Female; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1

2011
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1997, Volume: 6, Issue:4

    Topics: Adult; Aflatoxins; Aged; Anticarcinogenic Agents; Carcinoma, Hepatocellular; China; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Pyrazines; Thiones; Thiophenes

1997

Other Studies

6 other study(ies) available for pyrazines and Hepatitis B

ArticleYear
Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B.
    Internal medicine journal, 2013, Volume: 43, Issue:7

    Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Fatal Outcome; Hepatitis B; Humans; Male; Multiple Myeloma; Pyrazines

2013
Bortezomib inhibits hepatitis B virus replication in transgenic mice.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Animals; Antiviral Agents; Boronic Acids; Bortezomib; Cytokines; DNA, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Immunohistochemistry; Liver; Mice; Mice, Transgenic; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; Virus Replication

2010
Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2010, Volume: 21, Issue:2

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Hepatitis B; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence

2010
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Comorbidity; Endemic Diseases; Female; Hepatitis B; Humans; Immunologic Factors; Incidence; Lamivudine; Male; Middle Aged; Multiple Myeloma; Prevalence; Prospective Studies; Pyrazines; Retrospective Studies; Risk Factors; Secondary Prevention; Stem Cell Transplantation; Transplantation, Autologous; Virus Activation

2012
Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case report.
    Journal of clinical and experimental hematopathology : JCEH, 2012, Volume: 52, Issue:1

    Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Male; Multiple Myeloma; Pyrazines; Virus Activation

2012
Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz.
    The Journal of biological chemistry, 2000, Oct-27, Volume: 275, Issue:43

    Topics: Antiviral Agents; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Hepatitis B; Hepatitis B virus; Humans; Isoenzymes; Promoter Regions, Genetic; Pyrazines; RNA, Messenger; Sp1 Transcription Factor; Thiones; Thiophenes; Trans-Activators; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Viral Regulatory and Accessory Proteins

2000